Each vial contains Cefuroxime Sodium USP equivalent to Cefuroxime 750mg/1.5g.

Cefuroxime is a semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral administration.

Cefuroxime has invitro activity against a wide-range of gram-positive and gram-negative organisms and it is highly stable in the presence of beta-lactamases of certain gram negative bacteria. The bactericidal action of Cefuroxime results from inhibition of cell-wall synthesis.

The serum half-life after either IM or IV injection is approximately 80 minutes. Approximately 89% of a dose of Cefuroxime is excreted by the kidneys over an 8 hour period, resulting in high urinary concentrations. Cefuroxime is detectable in therapeutic concentrations in pleural fluid, joint fluid, bile, sputum, bone and aqueous humor. Cefuroxime is 50% bound to serum proteins.

Cefuroxime Injection is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases.

Zocef Injection is available in 750mg/1.5g Cefuroxime per vial.

Awards & Accolades

CEO of the Year - COYA Awards

The CEO & Director...

Read more ...
Corporate Citizenship & Environment

The CEO & Director...

Read more ...
Action is Awarded Superbrand Status
Our brands are recognized and loved by the families in 2008, Action was...
Maramoja is Awarded Superbrand Status
Our brands are recognized and loved by the family. In 2008...
Best Pharmaceutical Company In Tanzania 2014
Dr. Sanjay Advani accepts award in Pharmaceuticals and Medical Equipment Category from...
GLOBAL TRADE LEADER'S AWARD IN MADRID SPAIN
Beta Healthcare awarded with The...
Beta Healthcare International Ltd becomes an Aspen's Business Unit of the Year
International Award For Leadership in Image & Quality
GTL Award
Interview with UBC TV Uganda, Dr Sanjay Advani
Certificate of Leadership In Image & Quality